Accelus (formerly Integrity Implants) develops and manufactures medical implants used in spinal surgery.

Register for Details

For more details on financing and valuation for Accelus, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Accelus Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
12/27/2022 Series E $165.01MM $XXX.XX $XXX.XX
7/12/2022 Series D $350.02MM $XXX.XX $XXX.XX
2/1/2020 Series C $136.35MM $XXX.XX $XXX.XX
3/13/2019 Series B $106.65MM $XXX.XX $XXX.XX
4/21/2016 Series A $46.88MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Accelus

Forge green plus iconForge green minus icon

What is Accelus funding to date?

Accelus has raised $178.4MM with the following series:
$46.88MM for Series A, $106.65MM for Series B, $136.35MM for Series C, $350.02MM for Series D, $165.01MM for Series E, $46.88MM for Series A, $106.65MM for Series B, $136.35MM for Series C, $350.02MM for Series D, $165.01MM for Series E.
Forge green plus iconForge green minus icon

When was Accelus founded?

Accelus was founded in 2016.